Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT TEMOZOLOMIDE 20MG CAPSULE Resolved 2020-01-30 2020-07-09 104922
ACT TERBINAFINE 250MG TABLET Resolved 2020-07-23 2020-09-24 120905
ACT TERBINAFINE 250MG TABLET Resolved 2023-06-19 2023-08-17 195629
ACT TERBINAFINE 250MG TABLET Resolved 2025-01-30 2025-01-30 249182
ACT TERBINAFINE 250MG TABLET Resolved 2020-04-10 2023-10-03 111874
ACT TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240028
ACT TERBINAFINE 250MG TABLET Resolved 2023-02-09 2023-07-05 184195
ACT TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240037
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-04-28 176860
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-01-18 176791
ALERTEC 100MG TABLET Resolved 2022-08-18 2022-09-23 167165
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2025-04-04 2025-10-10 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Actual shortage 2025-06-19 2025-12-18 260642
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2025-06-05 2025-12-11 259685
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NAPROXEN SODIUM 275MG TABLET Discontinued 2025-05-28 2025-05-28 258522
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-NYSTATIN 100000UNIT CREAM Discontinued 2020-07-10 2020-07-10 120056
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63946
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63949
TEVA-OLMESARTAN 40MG TABLET Discontinued 2025-05-28 2025-05-28 258409
TEVA-OLMESARTAN 20MG TABLET Discontinued 2025-05-28 2025-05-28 258412
TEVA-OLMESARTAN / HCTZ 12.5MG 20MG TABLET Discontinued 2025-05-28 2025-05-28 258405
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Discontinued 2025-05-28 2025-05-28 258400
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Discontinued 2025-05-28 2025-05-28 258396
TEVA-ONDANSETRON 4MG TABLET Discontinued 2025-05-28 2025-05-28 258774
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-06-28 2024-06-29 231586
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-10-11 2024-10-11 240078
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2025-05-28 2025-05-28 258729
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2021-02-12 2021-02-12 133891
TEVA-PAROXETINE 20MG TABLET Discontinued 2019-12-09 2019-12-09 100547
TEVA-PAROXETINE 30MG TABLET Discontinued 2019-12-09 2019-12-09 100540
TEVA-PAROXETINE 20MG TABLET Reversed 2025-05-28 2025-06-04 258433
TEVA-PAROXETINE 20MG TABLET Reversed 2025-05-28 2025-06-04 258430